AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 24th, 2008 • Sirtris Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 24th, 2008 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT dated as of January 3, 2008 (the “Agreement”) is by and between Sirtris Pharmaceuticals, Inc. (the “Company”), a Delaware corporation with its principal place of business at 200 Technology Square, Cambridge, Massachusetts, and Christoph Westphal (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 24th, 2008 • Sirtris Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 24th, 2008 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT dated as of January 3, 2008 (the “Agreement”) is by and between Sirtris Pharmaceuticals, Inc. (the “Company”), a Delaware corporation with its principal place of business at 200 Technology Square, Cambridge, Massachusetts, and Peter Elliott (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 24th, 2008 • Sirtris Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 24th, 2008 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT dated as of January 3, 2008 (the “Agreement”) is by and between Sirtris Pharmaceuticals, Inc. (the “Company”), a Delaware corporation with its principal place of business at 200 Technology Square, Cambridge, Massachusetts, and Garen Bohlin (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 24th, 2008 • Sirtris Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 24th, 2008 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT dated as of January 3, 2008 (the “Agreement”) is by and between Sirtris Pharmaceuticals, Inc. (the “Company”), a Delaware corporation with its principal place of business at 200 Technology Square, Cambridge, Massachusetts, and Michael Jirousek (the “Executive”).